Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander A Morley

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Mutation Research|May 12, 2004
Cancer-associated genes can affect somatic intrachromosomal recombination early in carcinogenesisAntony M Hooker, Alexander A Morley, Wayne D Tilley, et al.
Mutation Research|March 14, 2002
Dose-dependent increase or decrease of somatic intrachromosomal recombination produced by etoposideAntony M Hooker, Rachel Horne, Alexander A Morley, et al.
Mutation Research|January 9, 2003
Mitotic recombination is an important mutational event following oxidative damageDavid R Turner, Monica Dreimanis, Deborah Holt, et al.
British Journal of Haematology|January 14, 2010
Rapid isolation of translocation breakpoints in chronic myeloid and acute promyelocytic leukaemiaPaul A Bartley, Michael H Martin-Harris, Bradley J Budgen, et al.
Haematologica|August 11, 2011
Durable complete molecular remission of chronic myeloid leukemia following dasatinib cessation, despite adverse disease featuresDavid M Ross, Paul A Bartley, Jarrad Goyne, et al.
Dose-Response : a Publication of International Hormesis Society|July 24, 2008
In vivo mutagenic effect of very low dose radiationPamela J Sykes, Tanya K Day, Sarah J Swinburne, et al.
Radiation Research|September 28, 2004
The linear no-threshold model does not hold for low-dose ionizing radiationAntony M Hooker, Madhava Bhat, Tanya K Day, et al.
Journal of Clinical Pathology|February 4, 2016
BCR-ABL1 expression, RT-qPCR and treatment decisions in chronic myeloid leukaemiaSusan Latham, Paul A Bartley, Bradley Budgen, et al.
The Journal of Molecular Diagnostics : JMD|January 3, 2015
A DNA real-time quantitative PCR method suitable for routine monitoring of low levels of minimal residual disease in chronic myeloid leukemiaPaul A Bartley, Susan Latham, Bradley Budgen, et al.
International Journal of Laboratory Hematology|May 25, 2010
Sensitive detection and quantification of minimal residual disease in chronic myeloid leukaemia using nested quantitative PCR for BCR-ABL DNAP A Bartley, D M Ross, S Latham, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Mutation Research|May 12, 2004
Cancer-associated genes can affect somatic intrachromosomal recombination early in carcinogenesisAntony M Hooker, Alexander A Morley, Wayne D Tilley, et al.
Mutation Research|March 14, 2002
Dose-dependent increase or decrease of somatic intrachromosomal recombination produced by etoposideAntony M Hooker, Rachel Horne, Alexander A Morley, et al.
Mutation Research|January 9, 2003
Mitotic recombination is an important mutational event following oxidative damageDavid R Turner, Monica Dreimanis, Deborah Holt, et al.
British Journal of Haematology|January 14, 2010
Rapid isolation of translocation breakpoints in chronic myeloid and acute promyelocytic leukaemiaPaul A Bartley, Michael H Martin-Harris, Bradley J Budgen, et al.
Haematologica|August 11, 2011
Durable complete molecular remission of chronic myeloid leukemia following dasatinib cessation, despite adverse disease featuresDavid M Ross, Paul A Bartley, Jarrad Goyne, et al.
Dose-Response : a Publication of International Hormesis Society|July 24, 2008
In vivo mutagenic effect of very low dose radiationPamela J Sykes, Tanya K Day, Sarah J Swinburne, et al.
Radiation Research|September 28, 2004
The linear no-threshold model does not hold for low-dose ionizing radiationAntony M Hooker, Madhava Bhat, Tanya K Day, et al.
Journal of Clinical Pathology|February 4, 2016
BCR-ABL1 expression, RT-qPCR and treatment decisions in chronic myeloid leukaemiaSusan Latham, Paul A Bartley, Bradley Budgen, et al.
The Journal of Molecular Diagnostics : JMD|January 3, 2015
A DNA real-time quantitative PCR method suitable for routine monitoring of low levels of minimal residual disease in chronic myeloid leukemiaPaul A Bartley, Susan Latham, Bradley Budgen, et al.
International Journal of Laboratory Hematology|May 25, 2010
Sensitive detection and quantification of minimal residual disease in chronic myeloid leukaemia using nested quantitative PCR for BCR-ABL DNAP A Bartley, D M Ross, S Latham, et al.
Pageof 3